You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,216,167


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,216,167 protect, and when does it expire?

Patent 9,216,167 protects ACULAR LS and is included in one NDA.

This patent has five patent family members in three countries.

Summary for Patent: 9,216,167
Title:Ketorolac tromethamine compositions for treating or preventing ocular pain
Abstract: Compositions comprising ketorolac tromethamine at a therapeutically effective concentration of less than 0.5% are disclosed herein. Methods of treating or preventing ocular pain using said compositions are also disclosed herein.
Inventor(s): Muller; Christopher A. (Foothill Ranch, CA), Cheetham; Janet K. (Laguna Niguel, CA), Kuan; Teresa H. (Placentia, CA), Power; David F. (Trabuco Canyon, CA)
Assignee: Allergan Sales, LLC. (Irvine, CA)
Application Number:14/533,798
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,216,167: A Comprehensive Analysis

Introduction

Patents are a cornerstone of innovation, providing exclusive rights to inventors and companies for their intellectual property. The United States Patent 9,216,167, like any other patent, is subject to a rigorous examination process to ensure its validity and scope. This article delves into the details of this patent, analyzing its claims, the patent landscape, and the implications of recent legal and regulatory developments.

Overview of the Patent

Patent Number and Title

The United States Patent 9,216,167 is a specific patent that, like all patents, has a unique title and description. To analyze this patent, one must first identify its title, inventors, and the assignee.

Inventors and Assignee

Understanding who the inventors and the assignee are is crucial as it provides context on the origins and ownership of the patent. This information can be found in the patent document itself or through databases like the USPTO Public Search Facility[4].

Claims Analysis

Types of Claims

Patent claims can be categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Claim Scope

The scope of the claims is a critical aspect of any patent. It determines what is protected and what is not. For example, the court in the Idenix vs. Gilead case highlighted the importance of claim scope, noting that overly broad claims can be invalid for lack of enablement under 35 U.S.C. § 112[2].

Enablement Requirement

The enablement requirement ensures that the patent specification provides sufficient guidance for a person of ordinary skill in the art (POSA) to make and use the invention. If the claims are too broad and the specification does not provide enough detail, the patent may be deemed invalid, as seen in the Idenix case[2].

Patent Landscape

Related Patents and Applications

Understanding the patent landscape involves identifying related patents and applications. Tools like the Global Dossier and the Common Citation Document (CCD) can help in this regard by providing access to file histories and citation data from participating IP offices[4].

Prior Art and Citations

Prior art and citations are essential in determining the novelty and non-obviousness of the invention. The CCD application consolidates prior art cited by all participating offices, making it easier to assess the patent's standing in the field[4].

Legal and Regulatory Considerations

Patent Eligibility Under 35 U.S.C. § 101

Recent court decisions have emphasized the importance of patent eligibility under 35 U.S.C. § 101. Patents must recite more than just abstract ideas or natural phenomena to be eligible. For instance, the court in Total Quality Systems, Inc. v. Universal Synaptics Corp. dismissed patent claims for intermittent fault detection technology as they failed to recite specific technological improvements over the prior art[5].

Patent Scope Metrics

Metrics such as independent claim length and independent claim count can be used to measure patent scope. These metrics have been shown to have explanatory power for several correlates of patent scope, including patent maintenance payments and forward citations[3].

Patent Examinations and Office Actions

Examination Process

The patent examination process is crucial in determining the validity and scope of the claims. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process than broader claims[3].

Office Actions and Indicators

Office actions can significantly impact the patent's scope. Tools like the Global Dossier provide Office Action Indicators to help users identify applications that contain office actions, aiding in the navigation of the examination process[4].

Impact of Court Decisions

Idenix vs. Gilead

The Idenix vs. Gilead case highlights the risks of overly broad claims. The court's decision to invalidate the '597 patent for lack of enablement serves as a cautionary tale for patent applicants to ensure their specifications provide adequate guidance[2].

Total Quality Systems, Inc. v. Universal Synaptics Corp.

This case underscores the importance of ensuring that patent claims are directed to more than just abstract ideas. The dismissal of the patent claims for intermittent fault detection technology due to lack of specific technological improvements is a significant precedent[5].

Practical Implications for Inventors and Companies

Drafting Claims

Inventors and companies must carefully draft claims to ensure they are neither too broad nor too narrow. The specification must provide sufficient detail to enable a POSA to make and use the invention.

Conducting Prior Art Searches

Thorough prior art searches are essential to ensure the novelty and non-obviousness of the invention. Tools provided by the USPTO, such as the Public Search Facility and PTRCs, can be invaluable in this process[4].

Global Patent System Integration

Global Dossier and CCD

The integration of global patent systems through services like the Global Dossier and CCD facilitates a more streamlined and harmonized approach to patent management. This can help in identifying related applications and prior art across different jurisdictions[4].

Conclusion

Understanding the scope and claims of a patent like United States Patent 9,216,167 involves a deep dive into the patent's specifics, the broader patent landscape, and relevant legal and regulatory considerations. By analyzing the claims, prior art, and legal precedents, inventors and companies can better navigate the complex world of intellectual property.

Key Takeaways

  • Claim Scope: The scope of the claims is critical and must be balanced to avoid being too broad or too narrow.
  • Enablement: The patent specification must provide sufficient guidance for a POSA to make and use the invention.
  • Patent Eligibility: Patents must recite more than just abstract ideas or natural phenomena to be eligible under 35 U.S.C. § 101.
  • Prior Art and Citations: Thorough searches are essential to ensure novelty and non-obviousness.
  • Global Integration: Tools like the Global Dossier and CCD aid in navigating the global patent system.

FAQs

What is the importance of claim scope in a patent?

Claim scope determines what is protected and what is not. Overly broad claims can be invalid for lack of enablement, while too narrow claims may not provide sufficient protection.

How does the enablement requirement impact patent validity?

The enablement requirement ensures that the patent specification provides enough detail for a POSA to make and use the invention. Failure to meet this requirement can result in the patent being deemed invalid.

What is the significance of 35 U.S.C. § 101 in patent eligibility?

35 U.S.C. § 101 ensures that patents are directed to more than just abstract ideas or natural phenomena. Claims must recite specific technological improvements to be eligible.

How can tools like the Global Dossier and CCD help in patent management?

These tools provide access to file histories, citation data, and office actions, facilitating a more streamlined and harmonized approach to patent management across different jurisdictions.

What are the practical implications of court decisions like Idenix vs. Gilead for patent applicants?

These decisions highlight the need for careful claim drafting and ensuring that the specification provides sufficient detail to enable a POSA to make and use the invention, avoiding overly broad claims.

Sources

  1. Approved Drug Products with Therapeutic Equivalence Evaluations, 36th Edition - DrugPatentWatch
  2. Court Kills Compound Patent For Failing to Enable Full Claim Scope - JD Supra
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO
  5. Court Dismisses Patent Claims Directed to Intermittent Fault Detection in Electrical Systems for Aircrafts as Ineligible Subject Matter Under 35 U.S.C. § 101 - Akin Gump

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,216,167

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie ACULAR LS ketorolac tromethamine SOLUTION/DROPS;OPHTHALMIC 021528-001 May 30, 2003 AT RX Yes Yes ⤷  Subscribe ⤷  Subscribe A METHOD OF TREATING OCULAR PAIN AND/OR ENHANCING OCULAR COMFORT ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,216,167

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2468664 ⤷  Subscribe
Canada 2967362 ⤷  Subscribe
European Patent Office 3217937 ⤷  Subscribe
European Patent Office 3777808 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2016077726 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.